BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10970094)

  • 21. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.
    Romieu-Mourez R; François M; Boivin MN; Stagg J; Galipeau J
    J Immunol; 2007 Aug; 179(3):1549-58. PubMed ID: 17641021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator.
    Lee PT; Holt PG; McWilliam AS
    Eur J Immunol; 2001 Aug; 31(8):2347-56. PubMed ID: 11477547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator.
    Pai RK; Askew D; Boom WH; Harding CV
    J Immunol; 2002 Aug; 169(3):1326-33. PubMed ID: 12133955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
    Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pRB is required for interferon-gamma-induction of the MHC class II abeta gene.
    Zhu X; Pattenden S; Bremner R
    Oncogene; 1999 Sep; 18(35):4940-7. PubMed ID: 10490828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation.
    Alfonso C; Liljedahl M; Winqvist O; Surh CD; Peterson PA; Fung-Leung WP; Karlsson L
    Immunol Rev; 1999 Dec; 172():255-66. PubMed ID: 10631951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.
    Mulder DJ; Pooni A; Mak N; Hurlbut DJ; Basta S; Justinich CJ
    Am J Pathol; 2011 Feb; 178(2):744-53. PubMed ID: 21281807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RAG cell line defines a new complementation group of MHC class II deficiency.
    Lennon A; Ottone C; Peijnenburg A; Hamon-Benais C; Colland F; Gobin S; van den Elsen P; Fellous M; Bono R; Alcaïde-Loridan C
    Immunogenetics; 1996; 43(6):352-9. PubMed ID: 8606055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A defective viral superantigen-presenting phenotype in HLA-DR transfectants is corrected by CIITA.
    Azar GA; Sékaly RP; Thibodeau J
    J Immunol; 2005 Jun; 174(12):7548-57. PubMed ID: 15944254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
    Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
    J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
    Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
    Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.